465 related articles for article (PubMed ID: 30134798)
1. Targeting DEC-205
Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
[TBL] [Abstract][Full Text] [Related]
2. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.
Yamazaki S; Dudziak D; Heidkamp GF; Fiorese C; Bonito AJ; Inaba K; Nussenzweig MC; Steinman RM
J Immunol; 2008 Nov; 181(10):6923-33. PubMed ID: 18981112
[TBL] [Abstract][Full Text] [Related]
3. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
4. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c
Kaushansky N; Kaminitz A; Allouche-Arnon H; Ben-Nun A
J Neuroimmunol; 2019 Aug; 333():476953. PubMed ID: 31108399
[TBL] [Abstract][Full Text] [Related]
5. Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells.
Stern JN; Keskin DB; Kato Z; Waldner H; Schallenberg S; Anderson A; von Boehmer H; Kretschmer K; Strominger JL
Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17280-5. PubMed ID: 20855626
[TBL] [Abstract][Full Text] [Related]
6. DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.
Price JD; Hotta-Iwamura C; Zhao Y; Beauchamp NM; Tarbell KV
Diabetes; 2015 Oct; 64(10):3521-31. PubMed ID: 26070317
[TBL] [Abstract][Full Text] [Related]
7. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
8. Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination.
Petzold C; Schallenberg S; Stern JN; Kretschmer K
Rev Diabet Stud; 2012; 9(4):305-18. PubMed ID: 23804268
[TBL] [Abstract][Full Text] [Related]
9. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease.
Ichikawa HT; Williams LP; Segal BM
J Immunol; 2002 Sep; 169(5):2781-7. PubMed ID: 12193753
[TBL] [Abstract][Full Text] [Related]
10. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance.
Kennedy KJ; Smith WS; Miller SD; Karpus WJ
J Immunol; 1997 Jul; 159(2):1036-44. PubMed ID: 9218627
[TBL] [Abstract][Full Text] [Related]
11. Induction of autoimmunity by expansion of autoreactive CD4+CD62Llow cells in vivo.
Amend B; Doster H; Lange C; Dubois E; Kalbacher H; Melms A; Bischof F
J Immunol; 2006 Oct; 177(7):4384-90. PubMed ID: 16982873
[TBL] [Abstract][Full Text] [Related]
12. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes.
Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK
Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442
[TBL] [Abstract][Full Text] [Related]
13. Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo.
Volckmar J; Knop L; Hirsch T; Frentzel S; Erck C; van Ham M; Stegemann-Koniszewski S; Bruder D
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33616089
[TBL] [Abstract][Full Text] [Related]
14. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813
[TBL] [Abstract][Full Text] [Related]
15. Selective depletion of CD11c
Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
[TBL] [Abstract][Full Text] [Related]
16. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study.
Cruz LJ; Rosalia RA; Kleinovink JW; Rueda F; Löwik CW; Ossendorp F
J Control Release; 2014 Oct; 192():209-18. PubMed ID: 25068703
[TBL] [Abstract][Full Text] [Related]
17. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo.
Soares H; Waechter H; Glaichenhaus N; Mougneau E; Yagita H; Mizenina O; Dudziak D; Nussenzweig MC; Steinman RM
J Exp Med; 2007 May; 204(5):1095-106. PubMed ID: 17438065
[TBL] [Abstract][Full Text] [Related]
18. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
[TBL] [Abstract][Full Text] [Related]
19. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.
Mukhopadhaya A; Hanafusa T; Jarchum I; Chen YG; Iwai Y; Serreze DV; Steinman RM; Tarbell KV; DiLorenzo TP
Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6374-9. PubMed ID: 18430797
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
Karpus WJ; Kennedy KJ; Smith WS; Miller SD
J Neurosci Res; 1996 Aug; 45(4):410-23. PubMed ID: 8872901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
